HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical models of Parkinson's disease.

Abstract
Parkinson's disease (PD) is a neurodegenerative disorder in which pigmented midbrain neurons progressively die producing a dopamine (DA) deficit in the striatum, which manifests as an akinetic movement disorder. Experimentally induced striatal DA depletion in animals is a valid model of parkinsonism. The capacity of certain substances to damage catecholaminergic neurons has been used extensively to produce DA deficiency in animals. This unit describes methods for inducing parkinsonism in nonhuman primates and rodents using the neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA). Additionally, procedures for evaluating the animals are presented.
AuthorsKrys S Bankiewicz, Rosario Sanchez-Pernaute, Yoshitsugu Oiwa, Malgorzata Kohutnicka, Alex Cummins, Jamie Eberling
JournalCurrent protocols in toxicology (Curr Protoc Toxicol) Vol. Chapter 1 Pg. Unit1.8 (Feb 2004) ISSN: 1934-9262 [Electronic] United States
PMID23045097 (Publication Type: Journal Article)
Chemical References
  • Levodopa
Topics
  • Animals
  • Disease Models, Animal
  • Levodopa (administration & dosage)
  • MPTP Poisoning
  • Macaca fascicularis
  • Macaca mulatta
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity
  • Parkinson Disease (physiopathology)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: